首页 | 本学科首页   官方微博 | 高级检索  
     

噻托溴铵联合沙美特罗/丙酸氟替卡松治疗慢性阻塞性肺疾病稳定期患者的疗效观察
引用本文:赵正宇,张爱观. 噻托溴铵联合沙美特罗/丙酸氟替卡松治疗慢性阻塞性肺疾病稳定期患者的疗效观察[J]. 国际呼吸杂志, 2011, 31(7): 490-492. DOI: 10.3760/cma.j.issn.1673-436X.2011.007.003
作者姓名:赵正宇  张爱观
作者单位:1. 平湖市第一人民医院呼吸科,314200
2. 平湖市中医院呼吸科,314200
摘    要:目的 观察沙美特罗/丙酸氟替卡松(舒利迭)联合噻托溴铵粉吸入剂(思力华)对慢性阻塞性肺疾病(COPD)缓解期的治疗效果.方法 采用随机、双肓的方法将85例COPD患者分为观察组和对照组,观察组A组给予噻托溴铵和沙美特罗/丙酸氟替卡松治疗,对照组B组给予沙美特罗/内酸氟替卡松治疗.分别对两组患者治疗前后的呼吸困难的评分、...

关 键 词:慢性阻塞性肺疾病  噻托溴铵  沙美特罗/丙酸氟替卡松  肺功能

Tiotropium bromide combined salmeterol/fluticasone propionate for the treatment in patients with stable chronic obstructive pulmonary disease
ZHAO Zheng-yu,ZHANG Ai-guan. Tiotropium bromide combined salmeterol/fluticasone propionate for the treatment in patients with stable chronic obstructive pulmonary disease[J]. International Journal of Respiration, 2011, 31(7): 490-492. DOI: 10.3760/cma.j.issn.1673-436X.2011.007.003
Authors:ZHAO Zheng-yu  ZHANG Ai-guan
Abstract:Objective To evaluate the effects of tiotropium bromide combined salmeterol/fluticasone propionate (SFC) for the treatment in patients with stable chronic obstructive pulmonary disease(COPD). Methods A randomized, double blind clinical trial was conducted in 85 patients with stable COPD. Group A was given tiotropium bromide combined with SFC,Group B was given SFC,the St George's respiratory questionnaire (SGRQ), pulmonary function and 6 minute walk distance (6-MWD)was conducted at baseline, 3 monthes after treatment. Results FEV1 , FEV1/FVC%, SGRQ score and 6-MWD in combined group A were significantly superior to those of control group B at 3 monthes after treatment (all P <0.05). Conclusions Tiotropium bromide combined SFC could further advance efficacy than SFC for the treatment in patients with stable COPD.
Keywords:Chronic obstructive pulmonary disease  Tiotropium bromide  Salmeterol/fluticasone propionate  Pulmonary function
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号